Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytovance® Biologics announced it has received a notification letter and an EIRs from the FDA for its Oklahoma City site, FEI registration numbers: 3006341547.
read more
Premier Pharmacy Labs is voluntarily recalling all unexpired products, intended to be sterile, due to a lack of sterility assurance.
read more
AssurX has announced that oral solid dose CDMO TEDOR Pharma has selected the AssurX platform to fully automate their quality and compliance management processes.
read more
Glenmark has received a CRL from the FDA for Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), Nasal Spray.
read more
Infinity Laboratories has added staff members to the company's team and recently expanded and purchased Ultimate Labs in San Diego.
read more
Scientist.com announced a partnership with Austrade, the Australian Trade and Investment Commission.
read more
LineaRx has shipped multiple customized linear DNA amplicons to Evotec SE, a therapeutic development company, to support their research efforts related to neurodegenerative diseases.
read more
TILT Biotherapeutics has entered into an agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate its armed oncolytic virus, TILT-123, with avelumab in patients with solid tumors refractory to routine modalities.
read more
Q2 Solutions conducted a sample tracking proof-of-concept (POC) using distributed ledger technology (DLT, aka blockchain) in partnership with HSBlox.
read more
Rafael Pharmaceuticals has entered into an out-licensing agreement with Ono Pharmaceutical.
read more
Lannett Company has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Capsules 25 mg, 50 mg and 100 mg.
read more
Just Biotherapeutics announced they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.
read more
Regis Technologies has announced a new capability of Solid State Chemistry.
read more
Catalent’s Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities.
read more
Cambrex has announced three senior appointments to further support the Contract development and Manufacturing Organization company.
read more